TG THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.34 USD | +1.67% |
|
+2.32% | -16.13% |
| Apr. 18 | Sector Update: Health Care Stocks Mixed in Late Afternoon Trading | MT |
| Apr. 18 | Sector Update: Health Care | MT |
Chart calendar TG Therapeutics, Inc.
54e2b58a994588.LbxOVAh42Q4JSAjUKmkf58PfQGOSM6_smpK3WVRs2qg.Gtc3Z2tArUE_FzCRHxMoqICwFC3GcOOu1ODePxAD7u4chCITXCehfUUdPA~956e4c623691c032f1a9d488cb3bfe31
Upcoming events on TG Therapeutics, Inc.
Past events on TG Therapeutics, Inc.
| 2024-04-17 10:00 am | American Academy of Neurology Meeting - Abstract No: 6023/017 |
| 2024-04-17 10:00 am | American Academy of Neurology Meeting - Abstract No: 6400/001 |
| 2024-04-14 07:30 pm | American Academy of Neurology Meeting - Abstract No: 6567/001 |
| 2024-02-29 06:00 pm | Americas Committee for Treatment and Research in Multiple Sclerosis Forum - Abstract Number: 731 |
| 2024-02-29 06:00 pm | Americas Committee for Treatment and Research in Multiple Sclerosis Forum - Abstract Number: 720 |
| 2024-02-28 08:30 am | Q4 2023 Earnings Call |
| 2024-02-28 07:00 am | Q4 2023 Earnings Release |
| 2024-01-09 07:30 pm | JPMorgan Healthcare Conference |
| 2023-11-29 02:10 pm | Evercore ISI HealthCONx Conference - Fireside Chat |
| 2023-11-06 03:10 pm | Guggenheim Securities Inflammation & Immunology Conference |
| 2023-11-01 08:30 am | Q3 2023 Earnings Call |
| 2023-11-01 07:30 am | Q3 2023 Earnings Release |
| 2023-10-12 11:00 am | European Committee for Treatment and Research in Multiple Sclerosis Meeting - Poster No: P641 |
| 2023-10-11 10:30 am | European Committee for Treatment and Research in Multiple Sclerosis Meeting - Poster No: P162 |
| 2023-10-11 02:00 am | European Committee for Treatment and Research in Multiple Sclerosis Meeting - Poster No: P1683 |
| 2023-09-26 12:25 pm | Cantor Global Healthcare Conference - Fireside Chat |
| 2023-09-11 10:30 am | H.C. Wainwright Global Investment Conference |
| 2023-08-01 08:30 am | Q2 2023 Earnings Call |
| 2023-08-01 07:15 am | Q2 2023 Earnings Release |
| 2023-06-14 09:30 am | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,15 0,17 -11.63% | 0,15 0,17 -9.52% | 6,69 6,97 -4% | 2,79 4,27 -34.74% | 234 231 1.12% | 265 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -344 -352 2.07% | -193 -173 -11.02% | 20,8 20,6 1.24% | 15,0 |
|
EBIT Million USD | Released Forecast Spread | -169 -172 1.67% | -274 -258 -6% | -345 -337 -2.3% | -193 -177 -8.89% | 20,6 18,7 10.47% | -10,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -173 -168 -2.97% | -279 -260 -7.62% | -348 -339 -2.62% | -198 -185 -7.23% | 13,1 10,4 26.19% | -14,1 |
|
Net income Million USD | Released Forecast Spread | -173 -173 0.2% | -279 -263 -6.12% | -348 -339 -2.61% | -198 -182 -9.06% | 12,7 11,6 8.8% | -16,4 |
|
EPS USD | Released Forecast Spread | -1,96 -1,97 0.51% | -2,42 -2,28 -6.01% | -2,63 -2,55 -3.15% | -1,46 -1,39 -5.42% | 0,09 0,08 12.82% | -0,12 |
| Announcement Date | 02/03/20 | 01/03/21 | 01/03/22 | 28/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,32 2,24 3.77% | 2,02 2,08 -2.86% | 0,59 0,18 238.6% | 0,09 1,70 -94.47% | 0,08 1,60 -95.01% | 7,80 3,38 130.93% | 16,1 17,9 -10.43% | 166 63,3 161.8% | 44,0 40,1 9.75% | 54,6 | 56,9 | 66,3 | 78,8 |
|
EBITDA Million USD | Released Forecast Spread | -92,9 -107 13.21% | -66,8 -92,0 27.4% | -38,9 -77,0 49.53% | -52,0 -42,0 -23.78% | -36,9 -52,0 28.99% | -44,6 -35,0 -27.55% | 115 97,0 18.41% | -12,4 -17,0 26.78% | 0,00 | -6,00 | -5,00 | 3,00 | |
|
EBIT Million USD | Released Forecast Spread | -92,9 -85,7 -8.43% | -66,9 -82,3 18.73% | -38,9 -72,7 46.45% | -35,0 -46,6 24.94% | -52,1 -36,5 -42.7% | -37,0 -50,2 26.31% | -44,7 -33,6 -32.92% | 115 4,26 2593.01% | -12,5 -15,5 19.62% | -6,13 | -9,60 | -5,58 | 1,58 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -93,3 -84,3 -10.67% | -69,0 -80,0 13.71% | -40,5 -61,7 34.29% | -35,8 -41,5 13.67% | -53,0 -39,7 -33.59% | -39,2 -52,3 25% | -47,6 -35,0 -35.99% | 114 45,8 148.9% | -14,0 -16,7 16.07% | -4,31 | -10,9 | -3,75 | 0,17 |
|
Net income Million USD | Released Forecast Spread | -93,3 -84,3 -10.67% | -69,0 -80,0 13.71% | -40,5 -66,4 38.96% | -35,8 -46,3 22.69% | -53,0 -36,6 -44.9% | -39,2 -52,3 25% | -47,6 -36,5 -30.48% | 114 51,1 122.83% | -14,4 -16,7 13.74% | -6,43 | -10,9 | -7,19 | -0,30 |
|
EPS USD | Released Forecast Spread | -0,70 -0,62 -12.97% | -0,51 -0,57 11.01% | -0,30 -0,47 36.33% | -0,26 -0,33 21.37% | -0,39 -0,25 -53.37% | -0,28 -0,35 19.42% | -0,34 -0,25 -33.71% | 0,73 0,17 329.41% | -0,10 -0,11 11.46% | -0,04 | -0,07 | -0,05 | -0,01 |
| Announcement Date | 01/03/22 | 10/05/22 | 08/08/22 | 09/11/22 | 28/02/23 | 01/05/23 | 01/08/23 | 01/11/23 | 28/02/24 | - | - | - | - |
| 2024-04-23 | SINO BIOLOGICAL,INC.: Q4 2023 Earnings Release |
| 2024-04-23 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-23 | CUREVAC N.V.: Q4 2023 Earnings Release |
| 2024-04-23 | ICON PUBLIC LIMITED COMPANY: Q1 2024 Earnings Release |
| 2024-04-23 | EVOTEC SE: Q4 2023 Earnings Release |
| 2024-04-24 01:45 am | ADDLIFE AB: Q1 2024 Earnings Release |
| 2024-04-24 | PHARMARON BEIJING CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-24 | SYNGENE INTERNATIONAL LIMITED: Q4 2024 Earnings Release |
| 2024-04-24 | HANGZHOU TIGERMED CONSULTING CO., LTD: Q1 2024 Earnings Release |
| 2024-04-24 | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Past sector events for TG Therapeutics, Inc.
| Today | SHANGHAI ALADDIN BIOCHEMICAL TECHNOLOGY CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| Today | HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q1 2024 Earnings Release |
| Today | HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q4 2023 Earnings Release |
| 2024-04-22 04:15 pm | MEDPACE HOLDINGS, INC.: Q1 2024 Earnings Release |
| 2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TGTX Stock
- Calendar TG Therapeutics, Inc.
